Telemedicine and mitigating the spread of COVID-19
The CDC is encouraging the liberal use of telehealth tools in response to the COVID-19 pandemic. Yet we have seen misunderstandings and misrepresentations of the power of virtual care in response to this pandemic in the media and in the public’s consciousness. Which is why we are creating this resource page to:
1.) Educate the market on the value of asynchronous virtual care in responding to COVID-19
2.) Sharing data and best practices we are seeing across the country
Zipnosis is committed to being THE front-line resource for every healthcare provider across the U.S.
Haven’t heard of Zipnosis before? We aren’t surprised—we’re the white-label virtual care platform powering the virtual care of health systems across the country. Our primary goal is empowering their local providers to give virtual care in their local communities. Since COVID-19’s arrival, Zipnosis has been committed to helping all of our healthcare providers and the 300M+ Americans they care for navigate this evolving pandemic.
The Value of Asynchronous Virtual Care:
Asynchronous virtual care allows a patient, on their own time, to answer a series of interview questions that adapt based on their responses. Those responses are then sent to a provider to review.
- Clinical Capacity:
Our asynchronous approach yields 12x clinical capacity over in-person care and over video/phone-based telemedicine. The average provider time for a Zipnosis visit in 2019 was 1 minute and 29 seconds, whereas the average phone/video-based telemedicine visit is about 18 minutes, and in-person care is even longer. That’s a 12x+ increase in efficiency. This will be key when health systems need to scale to meet pandemic-level visit volumes in their communities, something we are already seeing in select states.
- Rapid Updates:
In minutes, Zipnosis can push the latest evidence-based care into the field. This ensures we are keeping pace with the evolving CDC guidelines for COVID-19 screening. It also means each health system can customize, in real time, their patient education and patient routing recommendations.
- Localized Care:
Because we power the virtual care of health systems across the country, we use local providers for care. This means our platform makes localized recommendations for treatment, quarantine and other actions. It also means we’re collecting data at the local level and aggregating it into state and national trends. No other company has the reach and capability to do this.
- Reduced Clinical Variation:
Zipnosis’ clinical algorithms have helped achieve nearly 90% adherence to clinical guidelines for over a decade. Using proven systems, not individuals, leads to more consistent outcomes, especially as visit volume scales.
- Keeps patients out of clinic:
Patients with mild illness who may be infectious are able to be treated from home thank you to asynchronous virtual care. This means patients aren’t exposed to more serious infections in the public or in clinic, and that they’ll be less likely to infect others.
- Patient education within the protocols:
Our asynchronous protocols allow us to include patient education relevant to COVID-19 throughout the virtual visit experience. We are closely following CDC guidelines and consistent with national best practices. Our patient education includes information on staying healthy, handwashing, cough best practices, how to self-quarantine, and more.
Data and Best Practices
Updated: 4/3/20, 8:45am CST
Where does Zipnosis fit in?
Zipnosis is the white label virtual care platform powering the virtual care of health systems across the country. Empowering their local providers to give virtual care in their local communities. Because our average clinical work time is only 89 seconds, our health system partners are able to scale to meet the growing needs of this pandemic.
Hours of Clinical Work Time to Complete 220,978 COVID-19 virtual visits
Health System Partners
Health System Partners Offering Free COVID-19 Virtual Visits
Health System Partners Offering COVID-19 Screenings
Total Virtual Visits Volume
Completed Visits by Mode of Care
COVID-19 Patient Encounters Nationwide
The graph below displays the COVID-19 Screener and virtual visit data.
- First, the short COVID-19 screening assessment appropriately triages patients with COVID-19 concerns. Based on their responses, patients are either encouraged to start a virtual visit or provided with appropriate patient education based on their screener responses.
- Second, you can see our COVID-19 and Upper Respiratory Infection (URI) virtual visit volume. As both COVID-19 and URI have similar symptoms, and COVID-19 risk patients enter through both visit types, we are screening both for COVID-19 risk based on the CDC guidelines.
COVID-19 Screening and Virtual Visit Volume
External and Internal Task Forces
We have an external advisory council and internal task force that are actively managing Zipnosis’ COVID-19 response, including clinical updates, platform updates, community engagement, government affairs, and messaging.
Clinical Quality Advisory Council
Zipnosis COVID-19 Task Force
Best Practices for Health Systems Trying to Increase Public Awareness
Lessons learned on getting the word out about using virtual care (whether a patient thinks they have COVID-19 or another ailment) from our health systems across the country.
- Lead with asynchronous care options—average clinical work time for a Zipnosis visit in 2019 was 1 minute and 29 seconds. This will be key when health systems need to scale to meet pandemic-level visit volumes in their communities.
- Add a screening assessment to your virtual care homepage to a.) help patients better understand the symptoms of coronavirus, and b.) appropriately triage large numbers of patients with COVID-19 concerns. A COVID-19 screening assessment is currently available for Zipnosis customers.
- Encourage all visits to start virtually, even patients with other afflictions are being encouraged to avoid hospitals unless necessary.
- Offer free or reduced cost visits to encourage people to seek care virtually.
- On the homepage of your website make sure both the latest COVID-19 info and a link to virtual visits are immediately visible.
- Engage local employers to help spread the word.
- Engage your local and state health organizations and task forces.
- Engage your local media.
Telemedicine is NOT limited to “doing a video call with a doctor” or “texting a doctor.”
Asynchronous adaptive interview does not mean “interacting with an AI” or a “chatbot.”
You DON’T need to use another system to facilitate this (like Zoom or FaceTime).
This technology ALREADY EXISTS across the country. We don’t have to wait for Google or another tech company to invent it.
Lisa Ide, MD
Chief Medical Officer
Chief Operating Officer
The Zipnosis executive team is available for media interviews.
Reach out to Shaina Heberden, Sr. Marketing Communications Manager, at firstname.lastname@example.org with media inquiries.
“1000+ virtual visits for one MultiCare provider in a week is remarkable at face value–but it is even more awe-inspiring when you consider that one provider was able to keep over one-thousand patients out of the ED.
When multiplied across all of our providers, not just this one, then again over all the health systems Zipnosis work with, you’re looking at some extraordinary results and significant and far reaching benefits. All of this is possible because we can assess and treat patients in the Zipnosis asynchronous platform. Ben Chao and I are so thankful to the entire Zipnosis team that has worked around the clock for us so that we can do the same for our patients, our health system, and our entire community.”
STEPHANIE COWAN — Clinical Director, Virtual Care
MULTICARE HEALTH SYSTEM
“Thanks for all you and your team are doing. It is truly amazing and making such a difference in our ability to flatten the curve and take care of our patients. I can’t tell you how many times our incident command teams have said something along the lines of ‘Thank goodness for Zipnosis.'”
LAURA MENDYK — Medical Director
Put yourself at the forefront of a revolution.